| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | J Dinny Graham | |
| Christine L Clarke | |||
| Katherine M Scarpin | |||
| Patricia A Mote | |||
| P2860 | cites work | A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex | Q22009369 |
| Expression of progesterone receptors A and B in the mouse ovary during the estrous cycle | Q44814509 | ||
| DNA instructed displacement of histones H2A and H2B at an inducible promoter | Q45138457 | ||
| Murine progesterone receptor exists predominantly as the 83-kilodalton 'A' form | Q45215116 | ||
| A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms | Q45352912 | ||
| Receptor isoforms that mediate estrogen and progestagen action in the female lower urinary tract | Q46154702 | ||
| Comparing expression of progesterone and estrogen receptors in testicular tissue from men with obstructive and nonobstructive azoospermia | Q46331333 | ||
| Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development | Q46477275 | ||
| Systematic expression analysis and antibody screening do not support the existence of naturally occurring progesterone receptor (PR)-C, PR-M, or other truncated PR isoforms | Q46490362 | ||
| Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells. | Q46564578 | ||
| Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor | Q46686001 | ||
| Biochemical characterization and subunit structure of quail oviduct progesterone receptor | Q46920866 | ||
| Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo | Q24296381 | ||
| The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily | Q24530578 | ||
| The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding | Q24554243 | ||
| Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B | Q24556548 | ||
| Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor | Q24643098 | ||
| Distinct steady-state nuclear receptor coregulator complexes exist in vivo | Q24679780 | ||
| Progesterone receptors - animal models and cell signaling in breast cancer: Role of steroid receptor coactivators and corepressors of progesterone receptors in breast cancer | Q24802784 | ||
| Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells | Q24802807 | ||
| Sequence and characterization of a coactivator for the steroid hormone receptor superfamily | Q27860465 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| The steroid and thyroid hormone receptor superfamily | Q27861095 | ||
| The function of PML in p53-dependent apoptosis | Q28140732 | ||
| Combinatorial control of gene expression by nuclear receptors and coregulators | Q28209095 | ||
| Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 | Q28218453 | ||
| Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity | Q28218469 | ||
| The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT | Q28239712 | ||
| AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer | Q28245902 | ||
| Intranuclear Trafficking: Organization and Assembly of Regulatory Machinery for Combinatorial Biological Control | Q28315064 | ||
| The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development | Q28509946 | ||
| Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate | Q28578932 | ||
| Steroid receptor coactivator-1 from brain physically interacts differentially with steroid receptor subtypes | Q28582922 | ||
| Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform | Q28586470 | ||
| Nuclear receptor coregulators: cellular and molecular biology | Q29547588 | ||
| Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities | Q29615568 | ||
| A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform | Q30419213 | ||
| The Year in Basic Science: update of estrogen plus progestin therapy for menopausal hormone replacement implicating stem cells in the increased breast cancer risk | Q30485457 | ||
| Risk of breast cancer with progestins: critical assessment of current data | Q30885896 | ||
| Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth | Q33266857 | ||
| The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene | Q33766903 | ||
| Steroid hormone receptor expression and action in bone | Q33829036 | ||
| Nuclear receptors: one big family | Q34015466 | ||
| Dynamic cell type specificity of SRC-1 coactivator in modulating uterine progesterone receptor function in mice | Q34042802 | ||
| Progesterone receptor coactivators | Q34099992 | ||
| Nuclear matrix binding is critical for progesterone receptor movement into nuclear foci. | Q39927821 | ||
| Focal subnuclear distribution of progesterone receptor is ligand dependent and associated with transcriptional activity. | Q40223595 | ||
| E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. | Q40236413 | ||
| Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers | Q40287637 | ||
| Dual roles for the phosphatase PPM1D in regulating progesterone receptor function | Q40340400 | ||
| Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function. | Q40341667 | ||
| Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology. | Q40488240 | ||
| Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue. | Q40772612 | ||
| Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells | Q40862902 | ||
| Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways | Q40995230 | ||
| Localization of the glucocorticoid receptor in discrete clusters in the cell nucleus. | Q41300114 | ||
| Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function | Q41523742 | ||
| Physiological action of progesterone in target tissues | Q41574892 | ||
| Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. | Q42439064 | ||
| Differential effect of forms A and B of human progesterone receptor on estradiol-dependent transcription. | Q42833924 | ||
| The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome | Q43552379 | ||
| The N-terminal region of human progesterone B-receptors: biophysical and biochemical comparison to A-receptors | Q43592371 | ||
| Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium | Q43627814 | ||
| Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells | Q43805305 | ||
| New human breast cancer cells to study progesterone receptor isoform ratio effects and ligand-independent gene regulation | Q44000727 | ||
| Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium | Q44018218 | ||
| The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression | Q44061992 | ||
| Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium | Q44306864 | ||
| Loss of coordinated androgen regulation in nonmalignant ovarian epithelial cells with BRCA1/2 mutations and ovarian cancer cells | Q44443211 | ||
| Expression of estrogen receptor coregulators in normal and malignant human endometrium | Q44747963 | ||
| Expression of nuclear receptors and cofactors in human endometrium and myometrium | Q44774099 | ||
| Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium | Q44787029 | ||
| Breast cancer and hormone-replacement therapy in the Million Women Study | Q34223870 | ||
| Progesterone receptor transcription and non-transcription signaling mechanisms | Q34282690 | ||
| Role of molecular chaperones in steroid receptor action | Q34332069 | ||
| Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene | Q34460757 | ||
| Nuclear receptor coregulators and human disease | Q34645711 | ||
| The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? | Q34932849 | ||
| Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse | Q35071146 | ||
| The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors | Q35671179 | ||
| MCF10AT: a model for the evolution of cancer from proliferative breast disease | Q35773830 | ||
| The evolution of the nuclear receptor superfamily | Q35830301 | ||
| Nuclear structure in cancer cells | Q35877173 | ||
| Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling | Q35918601 | ||
| A contemporary understanding of progesterone receptor function | Q35947902 | ||
| Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes | Q35974510 | ||
| Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists | Q35975335 | ||
| Steroid Hormones, their receptors and neuroendocrine system | Q36369603 | ||
| Transcription activation by estrogen and progesterone receptors | Q36468309 | ||
| Integration of progesterone receptor action with rapid signaling events in breast cancer models | Q36580735 | ||
| An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk | Q36615906 | ||
| Steroid receptor coactivator 2 is essential for progesterone-dependent uterine function and mammary morphogenesis: insights from the mouse--implications for the human. | Q36625563 | ||
| The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells | Q36672641 | ||
| Challenges to defining a role for progesterone in breast cancer | Q36786766 | ||
| Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera | Q36800432 | ||
| Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation | Q36931106 | ||
| Coactivators and nuclear receptor transactivation | Q37130385 | ||
| E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors | Q37146105 | ||
| Cells in behaviourally relevant brain regions coexpress nuclear receptor coactivators and ovarian steroid receptors | Q37216588 | ||
| Progestin receptors: isoforms and antihormone action | Q37544485 | ||
| RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. | Q38308917 | ||
| Progesterone receptor isoforms A and B differentially regulate MUC1 expression in uterine epithelial cells. | Q38312696 | ||
| 5'-Heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated "C"-receptor and unique A-receptor messages | Q38338114 | ||
| Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis | Q38456582 | ||
| Gene regulation by steroid hormones | Q39166614 | ||
| Decreased expression of e6-associated protein in breast and prostate carcinomas | Q46964083 | ||
| Developmental regulation of murine mammary progesterone receptor gene expression. | Q52241264 | ||
| Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. | Q52571111 | ||
| Signalling through nuclear receptors. | Q53419452 | ||
| Overlapping and Distinct Expression of Progesterone Receptors A and B in Mouse Uterus and Mammary Gland during the Estrous Cycle | Q57287325 | ||
| In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity | Q57287565 | ||
| Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours | Q58433771 | ||
| Colocalization of Progesterone Receptors A and B by Dual Immunofluorescent Histochemistry in Human Endometrium during the Menstrual Cycle1 | Q60662131 | ||
| Purification of unactivated progesterone receptor and identification of novel receptor-associated proteins | Q68708793 | ||
| Evidence for a single steroid-binding protein in the rabbit progesterone receptor | Q68921807 | ||
| Two progesterone receptors in the oviduct of the freshwater turtle Chrysemys picta: possible homology to mammalian and avian progesterone receptor systems | Q69704840 | ||
| Rat uterine progesterone receptor analyzed by [3H]R5020 photoaffinity labeling: evidence that the A and B subunits are not equimolar | Q70169912 | ||
| Progesterone-binding components of chick oviduct. IV. Characterization of purified subunits | Q70349260 | ||
| Progesterone-binding protein of chick oviduct. VI. Interaction of purified progesterone-receptor components with nuclear constituents | Q70357116 | ||
| An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity | Q71788031 | ||
| Characterization of progesterone receptor A and B expression in human breast cancer | Q71804872 | ||
| Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors | Q72281048 | ||
| The ontogeny of gene expression of progestin receptors in the female rat brain | Q72689920 | ||
| Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer | Q73483264 | ||
| The N-terminal region of the human progesterone A-receptor. Structural analysis and the influence of the DNA binding domain | Q73509901 | ||
| An N-terminally truncated third progesterone receptor protein, PR(C), forms heterodimers with PR(B) but interferes in PR(B)-DNA binding | Q73962652 | ||
| Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform | Q74281193 | ||
| Expression of a subset of steroid receptor cofactors is associated with progesterone receptor expression in meningiomas | Q74352306 | ||
| Endometrial nuclear receptor co-factors SRC-1 and N-CoR are increased in human endometrium during menstruation | Q74373258 | ||
| Definition of a negative modulation domain in the human progesterone receptor | Q77221132 | ||
| Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland | Q79818790 | ||
| Progesterone receptor isoforms and proliferation in the rat mammary gland during development | Q79855496 | ||
| The p160 steroid receptor coactivator 2, SRC-2, regulates murine endometrial function and regulates progesterone-independent and -dependent gene expression | Q80447161 | ||
| Coactivator assembly at the promoter: efficient recruitment of SRC2 is coupled to cooperative DNA binding by the progesterone receptor | Q81225674 | ||
| Progesterone receptor isoforms in normal and malignant breast | Q81424333 | ||
| Estrogens, progestins, and risk of breast cancer | Q81424340 | ||
| Progesterone signaling in mammary gland development | Q81430432 | ||
| Turtle oviduct progesterone receptor: radioligand and immunocytochemical studies of changes during the seasonal cycle | Q82863407 | ||
| Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B | Q83954270 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | intracellular receptor | Q117980 |
| polycyclic compound | Q426145 | ||
| cell | Q7868 | ||
| hormone | Q11364 | ||
| nucleus | Q40260 | ||
| progesterone receptor | Q24783718 | ||
| P304 | page(s) | e009 | |
| P577 | publication date | 2009-12-31 | |
| P1433 | published in | Nuclear Receptor Signaling | Q15766610 |
| P1476 | title | Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression | |
| P478 | volume | 7 |
| Q90029662 | A mouse model engineered to conditionally express the progesterone receptor-B isoform |
| Q91619806 | A-Kinase Anchoring Protein 13 (AKAP13) Augments Progesterone Signaling in Uterine Fibroid Cells |
| Q42698187 | Accessing the molecular interactions of phthalates and their primary metabolites with the human pregnane X receptor using in silico profiling |
| Q36586384 | Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming |
| Q92263295 | An assessment of the multifactorial profile of steroid-metabolizing enzymes and steroid receptors in the eutopic endometrium during moderate to severe ovarian endometriosis |
| Q34224297 | Biological characterization of non-steroidal progestins from botanicals used for women's health. |
| Q24607818 | Botanical modulation of menopausal symptoms: mechanisms of action? |
| Q99635221 | Classical and Non-Classical Progesterone Signaling in Breast Cancers |
| Q51537682 | Conventional progesterone receptors (PR) B and PRA are expressed in human spermatozoa and may be involved in the pathophysiology of varicocoele: a role for progesterone in metabolism |
| Q33936650 | Decreased DNA Methylations at the Progesterone Receptor Promoter A Induce Functional Progesterone Withdrawal in Human Parturition. |
| Q53440345 | Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus. |
| Q99709764 | Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells |
| Q39236899 | Estrogens regulate life and death in mitochondria |
| Q89556171 | Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer |
| Q98178462 | Expression of Membrane Progesterone Receptors in Eutopic and Ectopic Endometrium of Women with Endometriosis |
| Q27011690 | GABAergic neuroactive steroids: a new frontier in bipolar disorders? |
| Q47787479 | Geraniol Inhibits Endometrial Carcinoma via Downregulating Oncogenes and Upregulating Tumour Suppressor Genes |
| Q33631532 | Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth |
| Q58113724 | In vitro antitumor activity of progesterone in human adrenocortical carcinoma |
| Q28260010 | Kaempferol Exhibits Progestogenic Effects in Ovariectomized Rats |
| Q41773989 | Ligand activated progesterone receptor B drives autophagy-senescence transition through a Beclin-1/Bcl-2 dependent mechanism in human breast cancer cells |
| Q33631557 | Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios? |
| Q35910912 | Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes |
| Q26825692 | Nuclear receptors and their selective pharmacologic modulators |
| Q47307932 | Progesterone Receptor Isoforms, Nuclear Corepressor-1 and Steroid Receptor Coactivator-1 and B-Cell Lymphoma 2 and Akt and Akt Phosphorylation Status in Uterine Myomas after Ulipristal Acetate Treatment: A Systematic Immunohistochemical Evaluation. |
| Q64949570 | Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression. |
| Q34608637 | Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP |
| Q35164020 | Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells |
| Q35603392 | Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells. |
| Q36906210 | Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells. |
| Q36277982 | Progesterone regulates the proliferation of breast cancer cells - in vitro evidence |
| Q36890286 | Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability |
| Q35181201 | Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters. |
| Q36350991 | Progestin modulates the lipid profile and sensitivity of breast cancer cells to docetaxel |
| Q49908076 | Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma |
| Q41478569 | Role of sex steroid hormones in bacterial-host interactions |
| Q50190951 | SUMOylation Regulates Transcription by the Progesterone Receptor A Isoform in a Target Gene Selective Manner |
| Q37186618 | Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies |
| Q45995811 | Sex-Dependent, Osteoblast Stage-Specific Effects of Progesterone Receptor on Bone Acquisition. |
| Q37798330 | Steroid hormone receptors in cancer development: A target for cancer therapeutics |
| Q89621112 | Steroids, Pregnancy and Fetal Development |
| Q35562822 | Structural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors |
| Q35868802 | The biology of progesterone receptor in the normal mammary gland and in breast cancer |
| Q36807752 | The requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specific |
| Q42026029 | The role of ovarian sex steroids in metabolic homeostasis, obesity, and postmenopausal breast cancer: molecular mechanisms and therapeutic implications. |
| Q54330083 | Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort. |
Search more.